Effects of hepatitis c seropositivity on erythropoietin requirement in end-stage renal failure patients receiving hemodialysis

Basit Öğe Kaydı
dc.authorid0000-0002-8087-9654en_US
dc.contributor.authorÇelebi, Aslan
dc.contributor.authorAvlağı, Gökalp Kurthan
dc.contributor.authorÖzdemir, Abbas
dc.contributor.authorKoç, Deniz Öğütmen
dc.contributor.authorGürler, Müjgan
dc.contributor.authorEkizoğlu, İsmail
dc.contributor.authorAltay, Murat
dc.date.accessioned2021-06-23T19:50:18Z
dc.date.available2021-06-23T19:50:18Z
dc.date.issued2018
dc.departmentBAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractBackground: Anemia and hepatitis C virus (HCV) infection are common problems encountered in patients with chronic renal failure (CRF). It has been reported that anemia is less common in HCV (+) hemodialysis patients because of increased endogenous erythropoietin (EPO) production. The present study is aimed to investigate the relation between anemia, EPO requirement, and HCV infection in CRF patients receiving hemodialysis. Methods: Medical records of the patients who had received hemodialysis for CRF between January 2013 and January 2014 in two private hemodialysis centers were retrospectively reviewed. Results: The mean age of the 52 patients included in the study was 59.50 +/- 14.28 years and 55.8% of them were females. There were 22 HCV (+) and 30 HCV (-) patients. There was no difference between HCV (+) and HCV (-) groups in terms of age and gender. Conclusion: HCV (+) patients had lower EPO requirement and ferritin levels, but higher total iron binding capacity and hemoglobin levels than that of HCV (-) patients.en_US
dc.identifier.doi10.19193/0393-6384_2018_2_72
dc.identifier.endpage456en_US
dc.identifier.issn0393-6384
dc.identifier.issn2283-9720
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-85043459616en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage453en_US
dc.identifier.urihttps://doi.org/10.19193/0393-6384_2018_2_72
dc.identifier.urihttps://hdl.handle.net/20.500.12491/9751
dc.identifier.volume34en_US
dc.identifier.wosWOS:000429278400026en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.institutionauthorGürler, Müjgan
dc.language.isoenen_US
dc.publisherCarbone Editoreen_US
dc.relation.ispartofActa Medica Mediterraneaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHemodialysisen_US
dc.subjectHepatitis Cen_US
dc.subjectAnemiaen_US
dc.subjectErythropoietinen_US
dc.titleEffects of hepatitis c seropositivity on erythropoietin requirement in end-stage renal failure patients receiving hemodialysisen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
aslan-celebi.pdf
Boyut:
182.89 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin/Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Dahili Tıp Bilimleri Bölümü Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu